C22H20N2O5
392.4 g/mol
원료의약품위험
7-Ethyl-10-hydroxycamptothecin
CAS86639-52-3
용도 분류
원료의약품
화합물 분류
기타
주요 용도
의약 원료
SN-38 is an antineoplastic compound and the active metabolite of irinotecan. It exhibits significantly higher cytotoxic activity than irinotecan itself, with relative potency varying widely in in vitro assays.
active pharmaceutical ingredientresearch compound for cytotoxicity studiesmetabolite of irinotecan
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 86639-52-3
관련 화합물
참고동일 카테고리
(3aS,4S,6aR)-4-Methoxytetrahydrofuro[3,4-b]furan-2(3H)-one
CAS866594-60-7
pharmaceutical impurity reference standard
참고동일 카테고리
(1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol
CAS866607-35-4
pharmaceutical intermediate
참고동일 카테고리
OSI 906
CAS867160-71-2
active pharmaceutical ingredient
참고동일 카테고리
6-Hydroxy-8-[(1R)-1-hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-2H-1,4-benzoxazin-3(4H)-one
CAS868049-49-4
Beta2-adrenergic agonist bronchodilator
참고same scaffold
10-Hydroxycamptothecin
CAS19685-09-7
active pharmaceutical ingredient
참고same scaffold
TOPOTECAN HYDROCHLORIDE
CAS119413-54-6
active pharmaceutical ingredient
참고same scaffold
Topotecan
CAS123948-87-8
active pharmaceutical ingredient
참고same scaffold
Chimmitecan
CAS185425-25-6
antineoplastic agent
안전 참조
위험
H301Toxic if swallowed
H341Suspected of causing genetic defects
식별자
IUPAC 이름
(19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
InChIKey
FJHBVJOVLFPMQE-QFIPXVFZSA-N
SMILES
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O
동의어 목록 (20)
- Irinotecan EP Impurity E; Camptothecin 7-Ethyl-10-Hydroxy Impurity
- 7-10-hydroxycamptothecin
- 7-Ethyl-10-hydroxy-20(S)-CPT
- SN 38
- SN 38 lactone
- SN-38 (Standard)
- SN-38(NK-012)?
- diethyl(dihydroxy)[?]dione